Backed by a $14 million CIRM award, Neurona Therapeutics is advancing a stem cell therapy that could transform epilepsy treatment without surgery or tissue damage. Learn more on our blog: blog.cirm.ca.gov/2025/06/20/n...
#neuroskyence #blueskybiotech #epilepsy #regenerativemedicine
#neuroskyence #blueskybiotech #epilepsy #regenerativemedicine
June 20, 2025 at 9:07 PM
Backed by a $14 million CIRM award, Neurona Therapeutics is advancing a stem cell therapy that could transform epilepsy treatment without surgery or tissue damage. Learn more on our blog: blog.cirm.ca.gov/2025/06/20/n...
#neuroskyence #blueskybiotech #epilepsy #regenerativemedicine
#neuroskyence #blueskybiotech #epilepsy #regenerativemedicine
Thank you to all the incredible trainees, program directors, patient advocates, and inspiring speakers who joined us for the 2025 #CIRMTraineeConference!
We’re grateful for the insights you shared and the community we continue to build together in advancing #RegenerativeMedicine. #BlueskyBiotech
We’re grateful for the insights you shared and the community we continue to build together in advancing #RegenerativeMedicine. #BlueskyBiotech
July 30, 2025 at 8:13 PM
Thank you to all the incredible trainees, program directors, patient advocates, and inspiring speakers who joined us for the 2025 #CIRMTraineeConference!
We’re grateful for the insights you shared and the community we continue to build together in advancing #RegenerativeMedicine. #BlueskyBiotech
We’re grateful for the insights you shared and the community we continue to build together in advancing #RegenerativeMedicine. #BlueskyBiotech
Millions live with painful osteoarthritis worldwide. A CIRM-funded clinical trial by Genascence reported positive early results using a gene therapy approach, demonstrating safety and sustained efficacy at 12 months.
Learn more on our blog at bit.ly/4nzlpzb
#BlueskyBiotech #Science #ClinicalTrials
Learn more on our blog at bit.ly/4nzlpzb
#BlueskyBiotech #Science #ClinicalTrials
July 8, 2025 at 7:28 PM
Millions live with painful osteoarthritis worldwide. A CIRM-funded clinical trial by Genascence reported positive early results using a gene therapy approach, demonstrating safety and sustained efficacy at 12 months.
Learn more on our blog at bit.ly/4nzlpzb
#BlueskyBiotech #Science #ClinicalTrials
Learn more on our blog at bit.ly/4nzlpzb
#BlueskyBiotech #Science #ClinicalTrials
💡The #FDA approved 50 new drugs in 2024, 64% of which were #SmallMolecules.
Find out more about the novel drug approval trends from the past 5 years and discover the structures of the small molecule drugs that are in the CSD 👉🔗 ccdc-info.com/3WIJWWz
#Pharmaceuticals #ChemSky #BlueskyBiotech
Find out more about the novel drug approval trends from the past 5 years and discover the structures of the small molecule drugs that are in the CSD 👉🔗 ccdc-info.com/3WIJWWz
#Pharmaceuticals #ChemSky #BlueskyBiotech
January 31, 2025 at 4:57 PM
💡The #FDA approved 50 new drugs in 2024, 64% of which were #SmallMolecules.
Find out more about the novel drug approval trends from the past 5 years and discover the structures of the small molecule drugs that are in the CSD 👉🔗 ccdc-info.com/3WIJWWz
#Pharmaceuticals #ChemSky #BlueskyBiotech
Find out more about the novel drug approval trends from the past 5 years and discover the structures of the small molecule drugs that are in the CSD 👉🔗 ccdc-info.com/3WIJWWz
#Pharmaceuticals #ChemSky #BlueskyBiotech
CIRM supports hands-on research training for students of all education levels. These highly trained students help power California’s $414 billion #LifeSciences industry and bring new treatments closer to patients.
Learn more about how we’re investing in people, and not just science. #BlueskyBiotech
Learn more about how we’re investing in people, and not just science. #BlueskyBiotech
20 Years of CIRM: Building the Workforce
In celebration of the California Institute for Regenerative Medicine (CIRM)’s 20th anniversary, we have been reflecting on some of the early projects we supported and their outcomes.Today, we’re lo…
blog.cirm.ca.gov
July 21, 2025 at 4:38 PM
CIRM supports hands-on research training for students of all education levels. These highly trained students help power California’s $414 billion #LifeSciences industry and bring new treatments closer to patients.
Learn more about how we’re investing in people, and not just science. #BlueskyBiotech
Learn more about how we’re investing in people, and not just science. #BlueskyBiotech
CIRM-funded @uclastemcell.bsky.social researchers reprogrammed blood #StemCells to produce #cancer-targeting T cells—offering a renewable path for immunotherapy. Early results are promising for treatment-resistant tumors.
#BlueskyBiotech
#BlueskyBiotech
UCLA scientists reprogram stem cells to create renewable cancer-fighting T cells
In a first-of-its-kind clinical trial, UCLA scientists have shown it’s possible to reprogram a patient’s blood-forming stem cells to generate a continuous supply of functional T cells, the immune syst...
stemcell.ucla.edu
September 10, 2025 at 4:20 PM
CIRM-funded @uclastemcell.bsky.social researchers reprogrammed blood #StemCells to produce #cancer-targeting T cells—offering a renewable path for immunotherapy. Early results are promising for treatment-resistant tumors.
#BlueskyBiotech
#BlueskyBiotech
The cryo-EM structure of a TnaC–ribosome complex shows how L-tryptophan stalls translation via a sequence-specific pocket in the exit tunnel (pubmed.ncbi.nlm.nih.gov/34403461) 
This is in prokaryotes but I’d bet the mechanism exists in eukaryotes.
#biotech #drugdiscovery #cryoEM #blueskybiotech
This is in prokaryotes but I’d bet the mechanism exists in eukaryotes.
#biotech #drugdiscovery #cryoEM #blueskybiotech
Structural basis of l-tryptophan-dependent inhibition of release factor 2 by the TnaC arrest peptide - PubMed
In Escherichia coli, elevated levels of free l-tryptophan (l-Trp) promote translational arrest of the TnaC peptide by inhibiting its termination. However, the mechanism by which translation-termination by the UGA-specific decoding release factor 2 (RF2) is inhibited at the UGA stop codon of stalled …
pubmed.ncbi.nlm.nih.gov
December 22, 2025 at 9:30 AM
The cryo-EM structure of a TnaC–ribosome complex shows how L-tryptophan stalls translation via a sequence-specific pocket in the exit tunnel (pubmed.ncbi.nlm.nih.gov/34403461) 
This is in prokaryotes but I’d bet the mechanism exists in eukaryotes.
#biotech #drugdiscovery #cryoEM #blueskybiotech
This is in prokaryotes but I’d bet the mechanism exists in eukaryotes.
#biotech #drugdiscovery #cryoEM #blueskybiotech
Entrepreneurs on the Move 💡
Jonathan will share his insights and experience in the challenges of commercializing tech, building sustainable scientific businesses, and leading through change in mission-driven organizations.
🔗 lnkd.in/e7U9wZvw
#BlueskyBiotech
Jonathan will share his insights and experience in the challenges of commercializing tech, building sustainable scientific businesses, and leading through change in mission-driven organizations.
🔗 lnkd.in/e7U9wZvw
#BlueskyBiotech
June 23, 2025 at 11:53 AM
Entrepreneurs on the Move 💡
Jonathan will share his insights and experience in the challenges of commercializing tech, building sustainable scientific businesses, and leading through change in mission-driven organizations.
🔗 lnkd.in/e7U9wZvw
#BlueskyBiotech
Jonathan will share his insights and experience in the challenges of commercializing tech, building sustainable scientific businesses, and leading through change in mission-driven organizations.
🔗 lnkd.in/e7U9wZvw
#BlueskyBiotech
Ever wonder how biomedical innovation actually works (or doesn’t?)
When everyone has an opinion about healthcare costs, and specifically drug prices, it helps to know how drugs happen.
#biosky #blueskybiotech
When everyone has an opinion about healthcare costs, and specifically drug prices, it helps to know how drugs happen.
#biosky #blueskybiotech
Biotech on Bluesky, I’m sharing with you first.
RA Capital just launched Biotech Unveiled, a free online course our team created.
Learn at own pace. Covers fundamentals of how insurance + investment direct R&D. Essential knowledge for leaders.
racap.thinkific.com/courses/biot...
RA Capital just launched Biotech Unveiled, a free online course our team created.
Learn at own pace. Covers fundamentals of how insurance + investment direct R&D. Essential knowledge for leaders.
racap.thinkific.com/courses/biot...
Biotech Unveiled: How the Biotech Industry Works
Designed to empower biotech professionals early in their career and set them up to succeed in the broader context in which they operate, this free mini-course is full of everything you've wanted to know about biotech but didn't know who to ask.
racap.thinkific.com
January 8, 2025 at 8:43 PM
Ever wonder how biomedical innovation actually works (or doesn’t?)
When everyone has an opinion about healthcare costs, and specifically drug prices, it helps to know how drugs happen.
#biosky #blueskybiotech
When everyone has an opinion about healthcare costs, and specifically drug prices, it helps to know how drugs happen.
#biosky #blueskybiotech